Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates, Lot to Lot Consistency and Antigen Interference With Co-Administered EPI Vaccines (Phase III)

NCT04185545 is registered in ClinicalTrials.gov with PT Bio Farma as lead sponsor.

NCT NCT04185545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04185545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates, Lot to Lot Consistency and Antigen Interference With Co-Administered EPI Vaccines (Phase III)
Lead sponsor
PT Bio Farma
Phase
Phase 3
Overall status
Completed
Start date
October 30, 2020
Completion date
May 30, 2023
Enrollment
1,400 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

rotavirus gastroenteritis